6 Multibagger Stocks That Surged After FIIs Corrected Their Mistakes

While Foreign Institutional Investors (FIIs) have largely been perceived as bears on Dalal Street, a fascinating trend has emerged among a select group of outlier stocks. In these specific counters, FIIs quietly reversed their selling stance and began accumulating shares, leading to massive multibagger returns for early movers.

The Anatomy of an FII U-Turn

The data from ACE Equity reveals a pattern where FIIs aggressively increased their stakes in the March 2026 quarter after systematically exiting positions in the preceding two quarters. This institutional course correction acted as a powerful catalyst for price appreciation in several mid-cap and small-cap names.

The most standout performer in this cohort is Bajaj Consumer Care, which delivered a staggering 265% return over the past year. FIIs had reduced their holding from 10.95% in June 2025 to 9.7% by December 2025, only to aggressively ramp up their stake to 16.59% in the March 2026 quarter. This pivot saw the stock price climb from ₹169.8 to ₹619.7.

High-Growth Stocks Driven by Institutional Re-entry

Several other stocks mirrored this trend, proving that even marginal shifts in institutional sentiment can trigger significant rallies:

  • Acutaas Chemicals: FII shareholding rose from 16.94% in June 2025 to 19.48% in March 2026, fueling a 187% price surge from ₹1,130.75 to ₹3,248.45.
  • SML Mahindra: After slashing stakes from 15.73% to a mere 0.61% by December 2025, FIIs pivoted back in March 2026, accompanying a 124.75% return.
  • Dee Development Engineers: A directional shift in FII holding (from 0.81% to 0.99%) helped the stock rise 119%, from ₹309.8 to ₹677.65.
  • United Foodbrands: Following a low point in September 2025, measured accumulation helped the stock appreciate 112%, moving from ₹316.7 to ₹672.
  • RateGain Travel Technologies: After dropping to 4.97% ownership, FIIs increased stakes to 5.35% by March 2026, helping the stock double from ₹431.9 to ₹873.25.

Diverging Expert Views on Future Market Direction

As the "smart money" recalibrates, Indian brokerages and fund houses remain divided on the next big move. Nuvama’s strategy team suggests that if global supply-side pressures ease, demand-driven sectors like consumer, chemicals, and IT will lead the charge. Conversely, JM Financial is adopting a defensive stance, favoring pharma, healthcare, and metals due to concerns over crude prices and rupee weakness.

Adding a different perspective, Tata Mutual Fund anticipates that a potential US slowdown could drive emerging market flows back toward India, favoring large-cap stocks due to their earnings stability. Meanwhile, Bandhan AMC’s Manish Gunwani identifies small caps as the most attractive space for a 3-to-5-year horizon, specifically pointing toward manufacturing, defence, and energy security infrastructure as key growth drivers.

Key Takeaways

  • Institutional Pivots Matter: Systematic FII re-entry after periods of selling can serve as a high-conviction signal for multibagger momentum.
  • Sectoral Divergence: While some experts favor defensive plays like pharma and consumer goods, others see long-term value in manufacturing and defence.
  • Valuation Discipline: Despite the rallies, analysts suggest that while small caps offer high growth potential, large caps remain a safer bet for stability amidst global macro uncertainty.